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Background: Smoking is a major risk factor for lung diseases and lower respiratory symptoms,
but since not all smokers develop chronic bronchitis and since chronic bronchitis is also diag-
nosed in never-smokers, it has been suggested that some individuals are more susceptible to
develop chronic bronchitis due to genetics.
Objective: To study the relative influence of genetic and environmental factors on the varia-
tion in the susceptibility to chronic bronchitis.
Methods: In a population-based questionnaire study of 13,649 twins, 50e71 years of age, from
the Danish Twin Registry, we calculated sex-specific concordance rates and heritability of
chronic bronchitis. The response rate was 75%.
Results: The prevalence of chronic bronchitis was 9.3% among men and 8.5% among women.
The concordance rate for chronic bronchitis was higher in monozygotic twins than in dizygotic
twins among women; 0.30 vs. 0.17, but not among men; 0.15 vs. 0.18. The heritability of
chronic bronchitis adjusted for smoking and age was 55% (36e71%) in women, whereas the sus-
ceptibility to chronic bronchitis in men for 25% (8e41%) was ascribable to familial environment
but not to genetic factors.
Conclusions: Chronic bronchitis shows a moderate familial aggregation, particularly in women.
Increased susceptibility to respiratory disease among female smokers relative to male smokers
may have a genetic origin.
ª 2014 Elsevier Ltd. All rights reserved.and Allergy Research Unit, Bisp
45 35312179.
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Chronic bronchitis is a disease characterized by chronic
cough and sputum from the airways for at least three
months in each of two successive years, as long as there are
no other causes of chronic cough [1]. The prevalence and
mortality associated with chronic obstructive pulmonary
disease (COPD) is increasing throughout the world and
COPD is estimated to be one of the most common causes of
death in 2020 [2,3]. COPD poses an important challenge for
society as consultation rates in primary care are high and
COPD exacerbations account for a substantial part of hos-
pital admissions [4].
Smoking is a well-known risk factor for chronic bron-
chitis and COPD [5] and the risk of chronic bronchitis in-
creases with the amount of tobacco consumed and with
age [5e8]. Pelkonen and colleagues found that by the age
of 75 years the cumulative incidence of chronic bronchitis
was 42% in continuous smokers, 26% in ex-smokers and
22% in never-smokers in the finnish population [9]. Other
risk factors such as farming, industrial work and asthma
have also been suggested [10e12]. Furthermore, some
studies have shown an association between passive
smoking during childhood and accelerated decline in lung
function and lower respiratory symptoms in adulthood
[13,14].
Smoking remains the major risk factor for chronic
bronchitis and COPD, but since not all smokers develop
obstructive respiratory disease, and more interestingly,
since chronic bronchitis and COPD have been diagnosed in
never-smokers, it has been suggested that the susceptibil-
ity could be due to genetics. The most important genetic
risk factor for COPD is a1-antitrypsin deficiency, which has
been known for several decades. However, a1-antitrypsin
deficiency only accounts for 1e2% of the susceptibility to
COPD in the population [15,16].
Previous studies have shown a familial aggregation of
obstructive pulmonary disease [17e21]. Furthermore, it has
been shown that women have a greater degree of airway
obstruction for a given amount of tobacco consumption
compared with men [22,23]. This low degree of airflow
obstruction was also found among non-smokers and in-
dividuals with less than five pack-years’ smoking history
[24] and it has been suggested that women are more sus-
ceptible to smoking induced diseases compared with men
[25,26].
Hallberg and colleagues have assessed to what extent
genetic factors contribute to the development of chronic
bronchitis [27]. The study, which examined Swedish twins,
found a moderate heritability of chronic bronchitis of 40%
[27]. Their criterion used to define chronic bronchitis was
wider than the classical criterion, which we have used in
our study. Furthermore, the Swedish authors dichotomized
smoking, using 10 pack e years as cutoff and thereby light
smokers were classified as nonsmokers.
Twin studies offer a powerful approach to examine the
impact of genes and environment on human diseases. The
aim of this study was, in a large Danish twin sample, to
study the relative influence of genetic and environmental
factors on the variation in susceptibility to chronic
bronchitis.Methods
Design
Data was collected from the Danish Twin Registry and the
present study sample comprised twins born between 1931
and 1952 [28]. These corresponded to 69% of all twin pairs
born in Denmark during these years. In 2002, these twins
(and twins born between 1953 and 1982) were sent a
multidisciplinary questionnaire concerning health and life-
style in which a history of smoking and chronic bronchitis
was recorded. The response rate to the questionnaire was
75%.
The study was approved by The Danish National Com-
mittee on Biomedical Research Ethics.
Study population
In total, 13,649 twin individuals (4030 intact pairs with
complete data on chronic bronchitis and smoking) were
from the cohort born 1931e1952. Chronic bronchitis was
defined as an affirmative response to the question ‘Have
you experienced at least three months per year of coughing
with production of phlegm during the past two years? Twin
zygosity was determined using four questions of similarity
and mistaken identity, which assign zygosity correctly in
more than 95% of the cases [29].
Statistical analysis
The prevalence and concordance rate for chronic bronchitis
were calculated for the different sex-by-zygosity groups.
The concordance rate denotes the probability that one twin
is affected given that the co-twin is affected. Since we
have complete ascertainment of twins the concordance
rate was estimated as two times the number of concordant
pairs (both twins are affected) divided by two times the
number of concordant affected pairs plus the number of
discordant pairs (one twin is affected) [30].
Latent factor models of genetic and environmental
factors were fitted to the raw data following the methods
described by Neale & Cardon [31]. These are customary
twin analyses assuming that the variation in the suscepti-
bility to chronic bronchitis can be partitioned into genetic
and environmental sources of variance. Genetic variance
can be further partitioned into additive genetic (loci
contributing additively to disease risk, A) and non-additive
genetic variance (interacting alleles, either from the same
locus e genetic dominance e or from separate loci e
epistasis, D). Environmental variance can be further parti-
tioned into shared environmental (environmental factors
that increase the resemblance between members of the
same family, C) and non-shared e random e environmental
variance (influences unique to individuals that result in
differences between family members, E) [32]. For most
human traits it is reasonable to assume that all four sources
of variance (A, D, C, and E) act simultaneously. However,
components C and D are not identified under the same
model in studies that include only twins reared together
[33]. Therefore, the likelihood of the data was determined
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and E since there was evidence that shared environment
could influence the disease liability (correlation in mono-
zygotic (MZ) twins below twice the correlation in dizygotic
(DZ) twins). The resulting expected phenotypic variance is
defined as the sum of these sources of variance, i.e.
A þ C þ E. Since MZ twins are genetically identical, the
expected covariance for MZ twins equals A þ C, while the
covariance between DZ twins, who share on average 50% of
their genes, equals 0.5*A þ C. The significance of the
contribution of the individual parameters to the variance in
disease liability was determined by a likelihood ratio test
for the difference between the full ACE model and subse-
quently fitted nested models (AE, CE and E models). The
statistical packages SPSS 20.0 (SPSS Inc., Chicago, IL) and
Mx was used for the analyses [34].
Results
The mean age of the study participants was 58.8 years and
52.7% were females. The overall prevalence of current
smokers in the population was 33%, whereas 30% were
former smokers. The prevalence of chronic bronchitis was
9.3% among men and 8.3% among women and there was no
significant difference in prevalence between men and
women, p Z 0.286. The population was divided into two
age groups, 50e59 and 60e71 years, in which the preva-
lence of chronic bronchitis was 8.4% and 9.6%, respectively,
p Z 0.01. The prevalence of chronic bronchitis in never
and former smoker was 4% and 6.1%, respectively,
p < 0.001. The total population of current smokers was
decomposed into three groups based on number of ciga-
rettes smoked per day; 1e10, 11e20 and 21þ, and the
prevalence in the three groups was 9.9%, 16.9% and 31.6
respectively. Compared with never-smokers current
smokers had an increased risk of chronic bronchitis in a
dose-dependent manner with an up to tenfold increased
risk in the heaviest smokers, OR Z 10.21 (7.93e13.15),
p < 0.001.
We found a higher concordance rate in MZ compared
with DZ twins among women, 0.30 vs. 0.17, pZ 0.166, but
not among men, 0.15 vs. 0.18, p Z 1.00 (Table 1).
Results from variance components analysis adjusted for
age and smoking are shown in Table 2. In women, a model
that included additive genetic effects and non-shared
environment best described the familial aggregation of
chronic bronchitis with a heritability of 55% (36e71%). In
men, the heritability of chronic bronchitis was small andTable 1 Resemblance between Danish twins for chronic bronch
Zygosity group Pairs (n) Affected (%) Discor
pairs
MZ
Males 430 66 (7.7) 56
Females 535 74 (6.9) 52
DZ
Males 683 123 (9.0) 101
Females 862 130 (7.5) 108
MZ, monozygotic; DZ, dizygotic same sex.statistically insignificant: 2% (0e52%), and susceptibility to
chronic bronchitis was best described by a model that
included only effects of shared and non-shared environ-
ment, with an estimate of shared environmental effects of
25% (8e41%).
Discussion
Previous studies have reported contradicting results
regarding the prevalence of chronic bronchitis in men and
women [7,27]. We did not find any significant difference in
the prevalence of chronic bronchitis between men and
women, and our data thereby support the results of another
large population-based study of Danish adults: The Copen-
hagen City Heart Study [7]. In contrast, we found a higher
concordance rate for chronic bronchitis among MZ women
compared with DZ women, but this was not the case for
men, indicating a genetic influence on the risk of devel-
oping chronic bronchitis in women, but not in men. This
pattern was further examined in a variance components
analysis adjusted for age and smoking. For women, we
found that the best fitting model describing susceptibility
to chronic bronchitis included additive genetic effects and
non-shared environmental affects with a heritability of
55%, suggesting a genetic predisposition to chronic bron-
chitis in women. However, the results for men did not
suggest a genetic predisposition to chronic bronchitis but
rather that familial aggregation was due to shared envi-
ronmental factors with a preferred model including only
shared and non-shared environmental effects.
When changing the outcome from the classical chronic
bronchitis definition to only include chronic cough and not
the time restriction, we found similar heritability
estimates.
A study of 44 probands with severe, early-onset COPD
performed by Silverman and colleagues found a signifi-
cantly increased risk of forced expiratory volume in the first
second (FEV1) <80% of predicted (OR Z 4.5) and an
increased risk of chronic bronchitis among current or ex-
smoking first-degree relatives, whereas no differences
were found in non-smoking subjects [17]. This suggests that
the increased risk of reduced FEV1 and chronic bronchitis
may relate to genotype-by-environment interaction be-
tween cigarette smoking and one or more genetic variants.
In a later report, Silverman and colleagues performed
another study of 40 early-onset COPD families and assessed
the sex-related differences in spirometric values, bron-
chodilator responsiveness and chronic bronchitis. Theyitis.
dant
(n)
Concordant
pairs (n)
Concordance
rate
P-value
5 0.15
11 0.30
11 0.18 1.0
11 0.17 0.166
Table 2 Variance components analysis of chronic bronchitis in Danish twins.
Variance componentsa Fit statistics
A C E De2 logQ Ddf P-value
Males
ACE 0.02 (0.00e0.52) 0.23 (0.00e0.41) 0.75 (0.48e0.92)
AE 0.33 (0.09e0.54) - 0.67 (0.46e0.91) 0.851 1 0.356
CE e 0.25(0.08e0.41) 0.75 (0.59e0.92) 0.002 1 0.963
E e e 1.00 7.98 2 0.019
Females
ACE 0.49 (0.00e0.71) 0.05 (0.00e0.47) 0.46 (0.29e0.68)
AE 0.55 (0.36e0.71) - 0.45 (0.29e0.64) 0.05d 1 0.817
CE e 0.40 (0.25e0.53) 0.60 (0.47e0.75) 2.80 1 0.094
E e e 1.00 28.06 2 0.000
For each model (ACE, AE, CE and E) variance components sum to 1.00 (100%); the preferred model based on parsimony and goodness of
fit is highlighted in bold print. The estimate of each component (A, C and E) is the proportion of the total phenotypic variance (sus-
ceptibility to disease) that is accounted for by the specific components.
De2 logQ, difference in model fit (log-likelihood) between saturated model and nested model.
Ddf, difference in degrees of freedom between saturated model and nested model.
Most parsimonious models are highlighted in bold.
a Variance components (95% confidence intervals) of chronic bronchitis susceptibility due to additive genetic factors (A), shared
environmental factors (C), and non-shared environmental factors (E) adjusted for age and smoking.
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bronchodilator responsiveness, but no increased risk of
chronic bronchitis in female first-degree relatives of early-
onset COPD probands [21]. Similar results were reported by
Montne´mery and colleagues, who found that familial
occurrence of chronic bronchitis/emphysema in first-
degree relatives is a stronger risk factor for development
for these traits than is smoking [18]. Another study by Patel
and colleagues showed familial aggregation of airway wall
thickening and emphysema, with siblings of an effected
proband having a more than twofold increased risk of
emphysema compared with controls [20]. Furthermore, the
authors reported that the association between airway wall
thickening and chronic cough and sputum production acts
as a marker of chronic bronchitis, characterized by mucus
hypersecretion. The authors concluded that, since smoking
is the only environmental exposure than confers this level
of risk, familial aggregation of the two major COPD phe-
notypes is due to genetic susceptibility [20].
Several studies have shown that women are more sus-
ceptible to smoking-induced respiratory diseases [22e26].
However it has not previously been shown whether this
susceptibility is due to genetic factors. It has been sug-
gested that more women smoke and that women are more
aware of symptoms than men. Moreover women seek health
care earlier or more often than men, and also tend to un-
derreport, whereas men tend to overreport their tobacco
consumption [8,35].
If women underreport phlegm, prevalence estimates of
CB may be too low. We cannot exclude that the observed
differences in resemblance and heritability of chronic
bronchitis in women and men may represent different
phenotypes measured in men and women. COPD with
mainly coughing symptoms in women may show decreased
heritability in COPD with phlegm in men. Thus, under-
reporting of phlegm in women will result in differences in
the variance components when comparing men andwomen. That women are more predisposed to develop
smoking-related respiratory disease could also be
explained by the differences in airway size as women may
be exposed to a greater amount of tobacco smoke than
men [35].
A criticism of twin studies it that they may overestimate
heritability. The argument being that monozygotic twins
are generally treated more similarly to each other than
dizygotic twins. E.g. parents often dress their identical
twins alike, treat them identically, and, in general, accent
their similarities. In this case, the MZ concordance would
increase relative to the DZ concordance [36].
It is uncertained whether this potential bias plays a role
in chronic bronchitis. However, studies on psychiatric dis-
orders have shown that the degree of environmental
sharing does not predict concordance rates [37].
Since data were self-reported we acknowledge limita-
tions such a recall bias and lack of clinical verification of
the airway symptoms. However, we used the definition set
by American Thoracic Society [1] and a good correlation
between self-reported chronic bronchitis and actual
sputum volume has been shown [38]. We did not take
occupation and outdoor pollution into consideration and
previous studies have shown associations between these
risk factors and respiratory symptoms [39,40]. Since our
study is nation-wide, it includes subjects from both rural
and urban areas in Denmark and therefore we do not
believe it would have changed our results considerably.
Conclusively, our study suggests that familial aggregation of
chronic bronchitis in women is mainly due to genetic fac-
tors, whereas the familial aggregation in men can be
ascribed to shared environmental factors. Therefore phy-
sicians should question all current and former smokers,
especially female patient, about their family history of
chronic bronchitis. Furthermore, we encourage physician to
be aware of undetected COPD in relatives to patients with
COPD.
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